Skip to main content
. Author manuscript; available in PMC: 2015 Oct 15.
Published in final edited form as: Cancer Res. 2014 Aug 21;74(20):5855–5865. doi: 10.1158/0008-5472.CAN-14-0799

Figure 2.

Figure 2

SAR405838 potently activates p53 in the SJSA-1 and HCT-116 cancer cell lines and strongly induces PUMA up-regulation and cleavage of caspase-3 and PARP in the SJSA-1 cell line but not in the HCT-116 cell line. (a–b). Analysis of dose-dependent transcriptional induction of p21, MDM2 and PUMA in both cell lines. (c–d). Analysis of dose-dependent induction of p53, p21, MDM2 and PUMA proteins and cleavage of caspase-3 and PARP in both cell lines.